EntreMed (ENMD) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: David Winkler who wrote (1508)	2/11/1999 8:06:00 PM
From: QuietWon	of 2135

Why the heck is everyone so hot and bothered about ENMD - still in phase II, still on mice. IMCL awaiting entry of phase III (and news today from CEO confirms it's coming), works on humans, 100% of persons in the trials had their tumors shrink by more than half, 88% had complete ie.100% disappearance of their tumours. Product is way closer to market than enmd. You heard the CEO it's a hundreds of millions market each year. Their drug C225 can be used in several areas of the body they believe, each needing separate FDA approval, so they have 'multi-products'. They have a lot of CASH - from their financial partner Merck. And yet ENMD's product very far behind, doesn't work, etc moves - only b/c ppl got overzealous a yr ago and so , remember the co's name. Well, their's a new name in town - IMCL !

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next